Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening

FDA Approves Expanded Use Of Lilly's FORTEO(R) [teriparatide (rDNA Origin) Injection] To Treat Glucocorticoid-Induced Osteoporosis
Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved a new use for its osteoporosis drug FORTEO((R)) [teriparatide (rDNA origin) injection] to treat osteoporosis associated with sustained, systemic glucocorticoid therapy in men and women at high risk of fracture. Glucocorticoid therapy is the most common cause of secondary osteoporosis, leading to bone loss and an increased risk for fracture.(1)
generic viagra online
WFP Appeals For $23M To Help Women, Children In Yemen
The World Food Programme (WFP) issued an urgent appeal on Tuesday for $23 million in "financial support from international donors for food aid to Yemen specifically targeted at women and children," AFP/Google.com reports. The agency said that the "figure represents 42 percent of the 55 million dollars that it needs for the current year to improve the nutrition of more than 1.6 million vulnerable people in Yemen," the news service writes.
plastic surgery before after
News of the day
White House Reform Chief Was On Boards Of Health Companies With Suspect Practices
Before taking her job as the White House health reform director, Nancy-Ann DeParle earned more than $6 million serving on the boards of major health care corporations, some of which were accused of fraud, mismanagement and regulatory violations during her tenure, the Investigative Reporting Workshop at American University reports on MSNBC.com. Some critics say the corporate relationships could be a conflict of interest for DeParle. Also, while there"s no evidence DeParle was involved in or aware of allegedly fraudulent activities, in three cases, she served on board committees overseeing the companies" legal and regulatory compliance.
Mental Health

American Medical Association Stands With President Obama At Historic Bill Signing On Tobacco Regulation

Statement attributable to: J. James Rohack, M.D. AMA President "As long-time advocates for strong regulation of the tobacco industry, the AMA is honored to stand with President Obama today as he signs the historic tobacco law. Today"s historic bill signing is a victory for public health over Big Tobacco. "More than 400,000 Americans die needlessly every year as a direct result of tobacco use. The actions resulting from this new law may make people think twice before picking up a cigarette. The sad truth is that tobacco-related deaths are the number one preventable cause of death in the U.S. Physicians are working not only to treat diseases like cancer and heart disease that result from tobacco use, but to prevent them from occurring in the first place. "The new law represents an important break from the past, as it signifies broad acceptance that nicotine is a drug harmful to people"s health. Tobacco companies will now have to disclose ingredients and use stronger warning labels. "New bans on all outdoor tobacco advertising within 1,000 feet of schools and playgrounds and on tobacco-brand sponsorships of sports and entertainment events will help keep tobacco advertising away from kids. Approximately 1,000 kids become new, regular smokers every day. These new marketing restrictions can help keep our kids away from cigarettes so they can become healthy adults." "With this bill signing, President Obama has again demonstrated his commitment to disease prevention and healthy lifestyles, which are both vital parts of the overall health reform the AMA is working for this year." American Medical Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009